Clinical Trials Browser

Phase 1/2 × Solid Tumor × donafenib × Clear all

NCT06239298 2024-06-14

A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor